Mutations in the low-density lipoprotein receptor gene in Swedish familial hypercholesterolaemia patients: clinical expression and treatment response. 1998

U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
Department of Clinical Chemistry, University Hospital of Lund, Sweden. ulf.ekstrom@klinkem.lu.se

BACKGROUND Familial hypercholesterolaemia, an autosomal co-dominant disorder caused by defects in the low-density lipoprotein receptor gene, is strongly associated with premature development of cardiovascular disease. METHODS In this study, we have applied a gene screening method in a population of familial hypercholesterolaemia patients in order to describe the genetic background of the disease in southern Sweden. These patients were studied with the aim of relating the presence of the different mutations to the clinical expression of the disease and to the response to pharmacological treatment. RESULTS In 16 out of 21 patients, potentially disease-causing low-density lipoprotein receptor gene defects were found, including five not previously described alterations (C240-->F, C122-->stop, C356-->Y, 785insG, 165delG). No defects in apolipoprotein B were found. One group of patients (n = 4) carried the mutation C122-->stop and another group of patients (n = 4) a mutation causing the substitution W66-->G. Patients in the two genotype subgroups were very similar with respect to lipid levels before treatment. CONCLUSIONS A tendency towards differential susceptibility to treatment with statins was observed for the patient groups, encouraging further comparative studies of heterozygous FH patients.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females

Related Publications

U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
May 1995, Molecular medicine today,
U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
December 2000, Journal of inherited metabolic disease,
U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
October 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
October 1992, Annals of medicine,
U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
December 2006, European journal of clinical investigation,
U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
January 2004, Kardiologiia,
U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
December 2004, Atherosclerosis. Supplements,
U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
October 1998, Arteriosclerosis, thrombosis, and vascular biology,
U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
May 1993, Lancet (London, England),
U Ekström, and M Abrahamson, and A Wallmark, and C H Florén, and P Nilsson-Ehle
August 1994, Trends in endocrinology and metabolism: TEM,
Copied contents to your clipboard!